Study indicates that TissueCypher® may detect a field effect associated with high grade dysplasia and can Read More
PITTSBURGH, PA – As part of its wide-ranging efforts to better target treatments t Read More
Test Predicts Development of Esophageal Cancer in Patients with Barrett’s Esophagus
Bethlehem, PA – Cernostics, Inc. Read More
Grant will further validate Cernostics’ diagnostic technology for predicting risk of future progression to Read More
US and Japanese patents cover the Company’s whole slide imaging and analy Read More
Collaboration will provide Cernostics with access to one of the largest B Read More
Funding will further develop a breakthrough diagnostic platform, producin Read More
DANVILLE, Pa. – John M. Inadomi, M.D., the Cyrus E. Rubin Professor of Medicine, and Division Chief, Gastroenterology, a Read More
DANVILLE, Pa. – Cernostics, a life science firm that develops and commercializes advanced cancer diagno Read More
(PITTSBURGH and DANVILLE, Pa). – Cernostics Inc., a biotechnology firm specializing in advanced cancer Read More